nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—Surgery—Nevirapine—acquired immunodeficiency syndrome	0.0374	0.0708	CcSEcCtD
L-Arginine—Surgical intervention—Nevirapine—acquired immunodeficiency syndrome	0.0374	0.0708	CcSEcCtD
L-Arginine—Paraesthesia oral—Amprenavir—acquired immunodeficiency syndrome	0.0204	0.0386	CcSEcCtD
L-Arginine—NOS3—endothelium—acquired immunodeficiency syndrome	0.0136	0.0359	CbGeAlD
L-Arginine—Paraesthesia oral—Indinavir—acquired immunodeficiency syndrome	0.0131	0.0247	CcSEcCtD
L-Arginine—NOS3—blood plasma—acquired immunodeficiency syndrome	0.012	0.0319	CbGeAlD
L-Arginine—SLC7A3—lung—acquired immunodeficiency syndrome	0.0119	0.0316	CbGeAlD
L-Arginine—ASL—digestive system—acquired immunodeficiency syndrome	0.0118	0.0313	CbGeAlD
L-Arginine—AZIN2—spinal cord—acquired immunodeficiency syndrome	0.0117	0.0309	CbGeAlD
L-Arginine—AZIN2—vagina—acquired immunodeficiency syndrome	0.0112	0.0298	CbGeAlD
L-Arginine—Paraesthesia oral—Ritonavir—acquired immunodeficiency syndrome	0.0109	0.0206	CcSEcCtD
L-Arginine—AZIN2—lung—acquired immunodeficiency syndrome	0.0106	0.0282	CbGeAlD
L-Arginine—Numbness—Didanosine—acquired immunodeficiency syndrome	0.0105	0.0199	CcSEcCtD
L-Arginine—Platelet count decreased—Indinavir—acquired immunodeficiency syndrome	0.0103	0.0195	CcSEcCtD
L-Arginine—SLC7A4—nervous system—acquired immunodeficiency syndrome	0.0103	0.0272	CbGeAlD
L-Arginine—Sensory loss—Didanosine—acquired immunodeficiency syndrome	0.0101	0.019	CcSEcCtD
L-Arginine—Necrosis—Nevirapine—acquired immunodeficiency syndrome	0.00999	0.0189	CcSEcCtD
L-Arginine—SLC7A4—central nervous system—acquired immunodeficiency syndrome	0.00988	0.0262	CbGeAlD
L-Arginine—ASL—lung—acquired immunodeficiency syndrome	0.00988	0.0262	CbGeAlD
L-Arginine—ARG2—retina—acquired immunodeficiency syndrome	0.00944	0.025	CbGeAlD
L-Arginine—ASL—nervous system—acquired immunodeficiency syndrome	0.00915	0.0242	CbGeAlD
L-Arginine—Numbness—Stavudine—acquired immunodeficiency syndrome	0.00913	0.0173	CcSEcCtD
L-Arginine—ASL—central nervous system—acquired immunodeficiency syndrome	0.00881	0.0233	CbGeAlD
L-Arginine—Sensory loss—Stavudine—acquired immunodeficiency syndrome	0.00874	0.0165	CcSEcCtD
L-Arginine—AZIN2—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00856	0.0912	CbGpPWpGaD
L-Arginine—Platelet count decreased—Saquinavir—acquired immunodeficiency syndrome	0.00828	0.0157	CcSEcCtD
L-Arginine—SLC7A4—brain—acquired immunodeficiency syndrome	0.00784	0.0208	CbGeAlD
L-Arginine—ASL—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00782	0.0834	CbGpPWpGaD
L-Arginine—SLC7A1—digestive system—acquired immunodeficiency syndrome	0.00775	0.0205	CbGeAlD
L-Arginine—AZIN2—brain—acquired immunodeficiency syndrome	0.00752	0.0199	CbGeAlD
L-Arginine—Skin exfoliation—Nevirapine—acquired immunodeficiency syndrome	0.00749	0.0142	CcSEcCtD
L-Arginine—Necrosis—Efavirenz—acquired immunodeficiency syndrome	0.00737	0.0139	CcSEcCtD
L-Arginine—AZIN2—lymph node—acquired immunodeficiency syndrome	0.00727	0.0193	CbGeAlD
L-Arginine—Necrosis—Delavirdine—acquired immunodeficiency syndrome	0.00705	0.0133	CcSEcCtD
L-Arginine—ASL—brain—acquired immunodeficiency syndrome	0.00699	0.0185	CbGeAlD
L-Arginine—ASL—lymph node—acquired immunodeficiency syndrome	0.00675	0.0179	CbGeAlD
L-Arginine—ARG2—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00648	0.0691	CbGpPWpGaD
L-Arginine—SLC7A1—lung—acquired immunodeficiency syndrome	0.00647	0.0172	CbGeAlD
L-Arginine—ARG2—blood—acquired immunodeficiency syndrome	0.00632	0.0167	CbGeAlD
L-Arginine—ARG2—spinal cord—acquired immunodeficiency syndrome	0.00608	0.0161	CbGeAlD
L-Arginine—SLC7A1—nervous system—acquired immunodeficiency syndrome	0.00599	0.0159	CbGeAlD
L-Arginine—ARG2—vagina—acquired immunodeficiency syndrome	0.00585	0.0155	CbGeAlD
L-Arginine—ASS1—skin of body—acquired immunodeficiency syndrome	0.00581	0.0154	CbGeAlD
L-Arginine—SLC7A1—central nervous system—acquired immunodeficiency syndrome	0.00577	0.0153	CbGeAlD
L-Arginine—ARG2—lung—acquired immunodeficiency syndrome	0.00554	0.0147	CbGeAlD
L-Arginine—Lethargy—Abacavir—acquired immunodeficiency syndrome	0.00553	0.0104	CcSEcCtD
L-Arginine—Skin exfoliation—Efavirenz—acquired immunodeficiency syndrome	0.00552	0.0104	CcSEcCtD
L-Arginine—Skin exfoliation—Delavirdine—acquired immunodeficiency syndrome	0.00528	0.00999	CcSEcCtD
L-Arginine—ARG2—nervous system—acquired immunodeficiency syndrome	0.00513	0.0136	CbGeAlD
L-Arginine—Swelling—Indinavir—acquired immunodeficiency syndrome	0.00504	0.00952	CcSEcCtD
L-Arginine—ARG2—central nervous system—acquired immunodeficiency syndrome	0.00494	0.0131	CbGeAlD
L-Arginine—NOS3—lymphoid tissue—acquired immunodeficiency syndrome	0.00469	0.0124	CbGeAlD
L-Arginine—ASS1—digestive system—acquired immunodeficiency syndrome	0.00465	0.0123	CbGeAlD
L-Arginine—NOS3—digestive system—acquired immunodeficiency syndrome	0.00463	0.0123	CbGeAlD
L-Arginine—SLC7A1—brain—acquired immunodeficiency syndrome	0.00458	0.0121	CbGeAlD
L-Arginine—Swelling—Delavirdine—acquired immunodeficiency syndrome	0.00455	0.00861	CcSEcCtD
L-Arginine—ASS1—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00449	0.0479	CbGpPWpGaD
L-Arginine—SLC7A1—lymph node—acquired immunodeficiency syndrome	0.00443	0.0117	CbGeAlD
L-Arginine—ASS1—blood—acquired immunodeficiency syndrome	0.00443	0.0117	CbGeAlD
L-Arginine—NOS3—blood—acquired immunodeficiency syndrome	0.00441	0.0117	CbGeAlD
L-Arginine—Hypoaesthesia—Didanosine—acquired immunodeficiency syndrome	0.00436	0.00824	CcSEcCtD
L-Arginine—ASS1—spinal cord—acquired immunodeficiency syndrome	0.00426	0.0113	CbGeAlD
L-Arginine—ASS1—vagina—acquired immunodeficiency syndrome	0.0041	0.0109	CbGeAlD
L-Arginine—Lethargy—Delavirdine—acquired immunodeficiency syndrome	0.0041	0.00775	CcSEcCtD
L-Arginine—NOS3—vagina—acquired immunodeficiency syndrome	0.00409	0.0108	CbGeAlD
L-Arginine—Sweating—Nelfinavir—acquired immunodeficiency syndrome	0.00407	0.0077	CcSEcCtD
L-Arginine—Sweating—Stavudine—acquired immunodeficiency syndrome	0.00406	0.00768	CcSEcCtD
L-Arginine—Haematuria—Stavudine—acquired immunodeficiency syndrome	0.00404	0.00764	CcSEcCtD
L-Arginine—ARG2—brain—acquired immunodeficiency syndrome	0.00392	0.0104	CbGeAlD
L-Arginine—ASS1—lung—acquired immunodeficiency syndrome	0.00388	0.0103	CbGeAlD
L-Arginine—NOS3—lung—acquired immunodeficiency syndrome	0.00387	0.0103	CbGeAlD
L-Arginine—NOS2—IL12-mediated signaling events—CCL4—acquired immunodeficiency syndrome	0.00386	0.0412	CbGpPWpGaD
L-Arginine—ARG2—lymph node—acquired immunodeficiency syndrome	0.00379	0.01	CbGeAlD
L-Arginine—Hypoaesthesia—Stavudine—acquired immunodeficiency syndrome	0.00378	0.00715	CcSEcCtD
L-Arginine—Lethargy—Saquinavir—acquired immunodeficiency syndrome	0.00365	0.0069	CcSEcCtD
L-Arginine—ASS1—nervous system—acquired immunodeficiency syndrome	0.00359	0.00953	CbGeAlD
L-Arginine—NOS3—nervous system—acquired immunodeficiency syndrome	0.00358	0.00949	CbGeAlD
L-Arginine—NOS2—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00354	0.0377	CbGpPWpGaD
L-Arginine—Sweating—Zidovudine—acquired immunodeficiency syndrome	0.00353	0.00667	CcSEcCtD
L-Arginine—Haematuria—Zidovudine—acquired immunodeficiency syndrome	0.00351	0.00664	CcSEcCtD
L-Arginine—ASS1—central nervous system—acquired immunodeficiency syndrome	0.00346	0.00917	CbGeAlD
L-Arginine—NOS3—central nervous system—acquired immunodeficiency syndrome	0.00345	0.00914	CbGeAlD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—CSF2—acquired immunodeficiency syndrome	0.00339	0.0361	CbGpPWpGaD
L-Arginine—SLC16A10—lymphoid tissue—acquired immunodeficiency syndrome	0.00336	0.00891	CbGeAlD
L-Arginine—Sweating—Indinavir—acquired immunodeficiency syndrome	0.00328	0.00621	CcSEcCtD
L-Arginine—Haematuria—Indinavir—acquired immunodeficiency syndrome	0.00326	0.00617	CcSEcCtD
L-Arginine—Anorexia—Amprenavir—acquired immunodeficiency syndrome	0.00325	0.00615	CcSEcCtD
L-Arginine—SLC16A10—blood—acquired immunodeficiency syndrome	0.00316	0.00838	CbGeAlD
L-Arginine—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00311	0.00588	CcSEcCtD
L-Arginine—Sweating—Efavirenz—acquired immunodeficiency syndrome	0.0031	0.00586	CcSEcCtD
L-Arginine—Haematuria—Efavirenz—acquired immunodeficiency syndrome	0.00308	0.00583	CcSEcCtD
L-Arginine—Hypoaesthesia—Indinavir—acquired immunodeficiency syndrome	0.00306	0.00578	CcSEcCtD
L-Arginine—Decreased appetite—Amprenavir—acquired immunodeficiency syndrome	0.00297	0.00561	CcSEcCtD
L-Arginine—Anorexia—Didanosine—acquired immunodeficiency syndrome	0.00297	0.00561	CcSEcCtD
L-Arginine—SLC22A4—digestive system—acquired immunodeficiency syndrome	0.00296	0.00784	CbGeAlD
L-Arginine—Haematuria—Delavirdine—acquired immunodeficiency syndrome	0.00295	0.00558	CcSEcCtD
L-Arginine—SLC16A10—vagina—acquired immunodeficiency syndrome	0.00293	0.00777	CbGeAlD
L-Arginine—Hypoaesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00289	0.00546	CcSEcCtD
L-Arginine—Flushing—Indinavir—acquired immunodeficiency syndrome	0.00285	0.00539	CcSEcCtD
L-Arginine—SLC22A4—blood—acquired immunodeficiency syndrome	0.00282	0.00747	CbGeAlD
L-Arginine—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.0028	0.00529	CcSEcCtD
L-Arginine—SLC22A5—retina—acquired immunodeficiency syndrome	0.00279	0.00738	CbGeAlD
L-Arginine—SLC16A10—lung—acquired immunodeficiency syndrome	0.00277	0.00735	CbGeAlD
L-Arginine—Hypoaesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00276	0.00523	CcSEcCtD
L-Arginine—ASS1—brain—acquired immunodeficiency syndrome	0.00275	0.00728	CbGeAlD
L-Arginine—Sweating—Ritonavir—acquired immunodeficiency syndrome	0.00274	0.00519	CcSEcCtD
L-Arginine—NOS3—brain—acquired immunodeficiency syndrome	0.00274	0.00726	CbGeAlD
L-Arginine—Haematuria—Ritonavir—acquired immunodeficiency syndrome	0.00273	0.00516	CcSEcCtD
L-Arginine—SLC22A4—bone marrow—acquired immunodeficiency syndrome	0.00273	0.00722	CbGeAlD
L-Arginine—SLC22A4—spinal cord—acquired immunodeficiency syndrome	0.00271	0.00719	CbGeAlD
L-Arginine—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.0027	0.00511	CcSEcCtD
L-Arginine—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.0027	0.0051	CcSEcCtD
L-Arginine—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.00267	0.00504	CcSEcCtD
L-Arginine—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00266	0.00503	CcSEcCtD
L-Arginine—ASS1—lymph node—acquired immunodeficiency syndrome	0.00265	0.00704	CbGeAlD
L-Arginine—NOS3—lymph node—acquired immunodeficiency syndrome	0.00265	0.00701	CbGeAlD
L-Arginine—NOS2—IL12-mediated signaling events—CCL3—acquired immunodeficiency syndrome	0.00264	0.0281	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00262	0.00495	CcSEcCtD
L-Arginine—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00261	0.00494	CcSEcCtD
L-Arginine—SLC22A4—vagina—acquired immunodeficiency syndrome	0.00261	0.00692	CbGeAlD
L-Arginine—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.00258	0.00488	CcSEcCtD
L-Arginine—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.00258	0.00487	CcSEcCtD
L-Arginine—Hypoaesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00256	0.00483	CcSEcCtD
L-Arginine—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.00254	0.0048	CcSEcCtD
L-Arginine—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.00252	0.00476	CcSEcCtD
L-Arginine—SLC22A4—lung—acquired immunodeficiency syndrome	0.00247	0.00654	CbGeAlD
L-Arginine—Hypoaesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00246	0.00465	CcSEcCtD
L-Arginine—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.00245	0.00648	CbGeAlD
L-Arginine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.00243	0.0046	CcSEcCtD
L-Arginine—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.00238	0.00451	CcSEcCtD
L-Arginine—NOS2—Type II interferon signaling (IFNG)—HLA-B—acquired immunodeficiency syndrome	0.00238	0.0254	CbGpPWpGaD
L-Arginine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.00236	0.00445	CcSEcCtD
L-Arginine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.00235	0.00444	CcSEcCtD
L-Arginine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00235	0.00444	CcSEcCtD
L-Arginine—Hypoaesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00235	0.00444	CcSEcCtD
L-Arginine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.00231	0.00437	CcSEcCtD
L-Arginine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00229	0.00433	CcSEcCtD
L-Arginine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00227	0.00429	CcSEcCtD
L-Arginine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.00224	0.00423	CcSEcCtD
L-Arginine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00218	0.00413	CcSEcCtD
L-Arginine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00217	0.0041	CcSEcCtD
L-Arginine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00215	0.00407	CcSEcCtD
L-Arginine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00215	0.00407	CcSEcCtD
L-Arginine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00214	0.00404	CcSEcCtD
L-Arginine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00211	0.00399	CcSEcCtD
L-Arginine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00208	0.00394	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.00208	0.0221	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.00208	0.0221	CbGpPWpGaD
L-Arginine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00206	0.0039	CcSEcCtD
L-Arginine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00204	0.00386	CcSEcCtD
L-Arginine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00203	0.00383	CcSEcCtD
L-Arginine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00201	0.00381	CcSEcCtD
L-Arginine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.002	0.00377	CcSEcCtD
L-Arginine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00199	0.00377	CcSEcCtD
L-Arginine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00199	0.00376	CcSEcCtD
L-Arginine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00198	0.00374	CcSEcCtD
L-Arginine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00197	0.00372	CcSEcCtD
L-Arginine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00196	0.00371	CcSEcCtD
L-Arginine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00196	0.00371	CcSEcCtD
L-Arginine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00196	0.00371	CcSEcCtD
L-Arginine—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.00196	0.00519	CbGeAlD
L-Arginine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00195	0.00369	CcSEcCtD
L-Arginine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00193	0.00364	CcSEcCtD
L-Arginine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00191	0.00361	CcSEcCtD
L-Arginine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.0019	0.00359	CcSEcCtD
L-Arginine—SLC16A10—lymph node—acquired immunodeficiency syndrome	0.0019	0.00503	CbGeAlD
L-Arginine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00188	0.00356	CcSEcCtD
L-Arginine—SLC22A5—blood—acquired immunodeficiency syndrome	0.00186	0.00494	CbGeAlD
L-Arginine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00185	0.00349	CcSEcCtD
L-Arginine—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.0018	0.00476	CbGeAlD
L-Arginine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00179	0.00339	CcSEcCtD
L-Arginine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00178	0.00337	CcSEcCtD
L-Arginine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00178	0.00336	CcSEcCtD
L-Arginine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00176	0.00334	CcSEcCtD
L-Arginine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00176	0.00334	CcSEcCtD
L-Arginine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00176	0.00333	CcSEcCtD
L-Arginine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00175	0.00331	CcSEcCtD
L-Arginine—SLC22A4—brain—acquired immunodeficiency syndrome	0.00175	0.00463	CbGeAlD
L-Arginine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00174	0.00329	CcSEcCtD
L-Arginine—SLC22A5—vagina—acquired immunodeficiency syndrome	0.00173	0.00458	CbGeAlD
L-Arginine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00172	0.00326	CcSEcCtD
L-Arginine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00172	0.00325	CcSEcCtD
L-Arginine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00172	0.00324	CcSEcCtD
L-Arginine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00171	0.00323	CcSEcCtD
L-Arginine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00171	0.00323	CcSEcCtD
L-Arginine—Rash—Stavudine—acquired immunodeficiency syndrome	0.0017	0.00322	CcSEcCtD
L-Arginine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.0017	0.00322	CcSEcCtD
L-Arginine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.0017	0.00321	CcSEcCtD
L-Arginine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.0017	0.00321	CcSEcCtD
L-Arginine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00169	0.0032	CcSEcCtD
L-Arginine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00169	0.0032	CcSEcCtD
L-Arginine—SLC22A4—lymph node—acquired immunodeficiency syndrome	0.00169	0.00448	CbGeAlD
L-Arginine—NOS2—IL12-mediated signaling events—CD8A—acquired immunodeficiency syndrome	0.00168	0.0179	CbGpPWpGaD
L-Arginine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00168	0.00317	CcSEcCtD
L-Arginine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00168	0.00317	CcSEcCtD
L-Arginine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00168	0.00317	CcSEcCtD
L-Arginine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00167	0.00317	CcSEcCtD
L-Arginine—Headache—Abacavir—acquired immunodeficiency syndrome	0.00167	0.00315	CcSEcCtD
L-Arginine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00166	0.00314	CcSEcCtD
L-Arginine—NOS2—IL12-mediated signaling events—IL4—acquired immunodeficiency syndrome	0.00165	0.0176	CbGpPWpGaD
L-Arginine—SLC22A5—lung—acquired immunodeficiency syndrome	0.00163	0.00433	CbGeAlD
L-Arginine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00162	0.00306	CcSEcCtD
L-Arginine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00161	0.00304	CcSEcCtD
L-Arginine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00161	0.00304	CcSEcCtD
L-Arginine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.0016	0.00303	CcSEcCtD
L-Arginine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.0016	0.00302	CcSEcCtD
L-Arginine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00159	0.003	CcSEcCtD
L-Arginine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00158	0.00299	CcSEcCtD
L-Arginine—AZIN2—Metabolism—TAT—acquired immunodeficiency syndrome	0.00157	0.0167	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—CCR5—acquired immunodeficiency syndrome	0.00154	0.0164	CbGpPWpGaD
L-Arginine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00153	0.00289	CcSEcCtD
L-Arginine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00152	0.00287	CcSEcCtD
L-Arginine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00149	0.00282	CcSEcCtD
L-Arginine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00148	0.0028	CcSEcCtD
L-Arginine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00148	0.0028	CcSEcCtD
L-Arginine—NOS2—IL23-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.00147	0.0157	CbGpPWpGaD
L-Arginine—NOS2—Type II interferon signaling (IFNG)—IFNG—acquired immunodeficiency syndrome	0.00147	0.0157	CbGpPWpGaD
L-Arginine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00147	0.00278	CcSEcCtD
L-Arginine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00146	0.00275	CcSEcCtD
L-Arginine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00145	0.00275	CcSEcCtD
L-Arginine—ASL—Metabolism—TAT—acquired immunodeficiency syndrome	0.00144	0.0153	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.00142	0.0151	CbGpPWpGaD
L-Arginine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00139	0.00264	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.00139	0.0148	CbGpPWpGaD
L-Arginine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00139	0.00263	CcSEcCtD
L-Arginine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00138	0.0026	CcSEcCtD
L-Arginine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00138	0.0026	CcSEcCtD
L-Arginine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00137	0.00259	CcSEcCtD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—ACTG1—acquired immunodeficiency syndrome	0.00135	0.0143	CbGpPWpGaD
L-Arginine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00134	0.00254	CcSEcCtD
L-Arginine—AZIN2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00134	0.0142	CbGpPWpGaD
L-Arginine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00131	0.00248	CcSEcCtD
L-Arginine—NOS2—IL23-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.00131	0.0139	CbGpPWpGaD
L-Arginine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.0013	0.00246	CcSEcCtD
L-Arginine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.0013	0.00246	CcSEcCtD
L-Arginine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.0013	0.00245	CcSEcCtD
L-Arginine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00129	0.00245	CcSEcCtD
L-Arginine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00129	0.00244	CcSEcCtD
L-Arginine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00126	0.00237	CcSEcCtD
L-Arginine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00124	0.00235	CcSEcCtD
L-Arginine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00124	0.00235	CcSEcCtD
L-Arginine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00124	0.00234	CcSEcCtD
L-Arginine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00123	0.00233	CcSEcCtD
L-Arginine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00123	0.00232	CcSEcCtD
L-Arginine—ASL—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00122	0.013	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—TAT—acquired immunodeficiency syndrome	0.00119	0.0127	CbGpPWpGaD
L-Arginine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00117	0.00222	CcSEcCtD
L-Arginine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00116	0.00219	CcSEcCtD
L-Arginine—SLC22A5—brain—acquired immunodeficiency syndrome	0.00116	0.00307	CbGeAlD
L-Arginine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.00218	CcSEcCtD
L-Arginine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.00217	CcSEcCtD
L-Arginine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00114	0.00216	CcSEcCtD
L-Arginine—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.00112	0.00296	CbGeAlD
L-Arginine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00112	0.00211	CcSEcCtD
L-Arginine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.00209	CcSEcCtD
L-Arginine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.00209	CcSEcCtD
L-Arginine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.0011	0.00208	CcSEcCtD
L-Arginine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00108	0.00205	CcSEcCtD
L-Arginine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00107	0.00202	CcSEcCtD
L-Arginine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00106	0.002	CcSEcCtD
L-Arginine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00106	0.002	CcSEcCtD
L-Arginine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00105	0.00199	CcSEcCtD
L-Arginine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00197	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.00101	0.0108	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00101	0.0108	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.001	0.0107	CbGpPWpGaD
L-Arginine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000996	0.00188	CcSEcCtD
L-Arginine—NOS2—IL12-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.000965	0.0103	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000963	0.0103	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.000953	0.0101	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000888	0.00947	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000825	0.00879	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—IFNG—acquired immunodeficiency syndrome	0.000798	0.0085	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000769	0.00819	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—IL2—acquired immunodeficiency syndrome	0.000709	0.00755	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000702	0.00748	CbGpPWpGaD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000678	0.00723	CbGpPWpGaD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000631	0.00672	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—acquired immunodeficiency syndrome	0.000597	0.00636	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.000582	0.0062	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.000581	0.00619	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	0.000529	0.00564	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000517	0.00551	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	0.00049	0.00522	CbGpPWpGaD
L-Arginine—NOS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000442	0.00471	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—IL6—acquired immunodeficiency syndrome	0.000417	0.00444	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.00039	0.00416	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	0.000377	0.00401	CbGpPWpGaD
L-Arginine—NOS2—Disease—CCNT1—acquired immunodeficiency syndrome	0.000376	0.004	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TAT—acquired immunodeficiency syndrome	0.000359	0.00383	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000345	0.00367	CbGpPWpGaD
L-Arginine—NOS3—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000343	0.00365	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000337	0.00359	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.00032	0.00341	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000305	0.00325	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000305	0.00325	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	0.000304	0.00324	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000303	0.00323	CbGpPWpGaD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000295	0.00315	CbGpPWpGaD
L-Arginine—NOS3—Disease—CCNT1—acquired immunodeficiency syndrome	0.000292	0.00311	CbGpPWpGaD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000291	0.0031	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—ALB—acquired immunodeficiency syndrome	0.000274	0.00292	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	0.000255	0.00272	CbGpPWpGaD
L-Arginine—ASL—Metabolism—ALB—acquired immunodeficiency syndrome	0.000251	0.00267	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	0.000241	0.00257	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000237	0.00253	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000222	0.00236	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ALB—acquired immunodeficiency syndrome	0.000208	0.00221	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000204	0.00218	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000204	0.00218	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000199	0.00212	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000198	0.00212	CbGpPWpGaD
L-Arginine—NOS2—Disease—CXCR4—acquired immunodeficiency syndrome	0.000197	0.0021	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.00019	0.00202	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000185	0.00197	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000161	0.00172	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000154	0.00165	CbGpPWpGaD
L-Arginine—NOS3—Disease—CXCR4—acquired immunodeficiency syndrome	0.000153	0.00163	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.00015	0.0016	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000148	0.00157	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ALB—acquired immunodeficiency syndrome	0.000144	0.00153	CbGpPWpGaD
L-Arginine—NOS2—Disease—CCR5—acquired immunodeficiency syndrome	0.000135	0.00144	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000126	0.00134	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000125	0.00133	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000114	0.00122	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000113	0.0012	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000107	0.00114	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000107	0.00114	CbGpPWpGaD
L-Arginine—NOS3—Disease—CCR5—acquired immunodeficiency syndrome	0.000105	0.00112	CbGpPWpGaD
L-Arginine—NOS2—Disease—CD4—acquired immunodeficiency syndrome	8.49e-05	0.000905	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.16e-05	0.000869	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.04e-05	0.000856	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.35e-05	0.000783	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD4—acquired immunodeficiency syndrome	6.59e-05	0.000702	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ALB—acquired immunodeficiency syndrome	6.26e-05	0.000667	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6—acquired immunodeficiency syndrome	4.59e-05	0.000489	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.25e-05	0.000453	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6—acquired immunodeficiency syndrome	3.56e-05	0.00038	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.5e-05	0.000266	CbGpPWpGaD
